NEW YORK, Dec. 20, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Intellia Therapeutics, Inc. (NASDAQ:NTLA), United Community Banks, Inc. (NASDAQ:UCBI), CytomX Therapeutics, Inc. (NASDAQ:CTMX), First Interstate BancSystem, Inc. (NASDAQ:FIBK), Global Net Lease, Inc. (NYSE:GNL), and Enable Midstream Partners, LP (NYSE:ENBL), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

NTLA DOWNLOAD: http://Fundamental-Markets.com/register/?so=NTLA
UCBI DOWNLOAD: http://Fundamental-Markets.com/register/?so=UCBI
CTMX DOWNLOAD: http://Fundamental-Markets.com/register/?so=CTMX
FIBK DOWNLOAD: http://Fundamental-Markets.com/register/?so=FIBK
GNL DOWNLOAD: http://Fundamental-Markets.com/register/?so=GNL
ENBL DOWNLOAD: http://Fundamental-Markets.com/register/?so=ENBL

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Intellia Therapeutics, Inc. (NASDAQ:NTLA), United Community Banks, Inc. (NASDAQ:UCBI), CytomX Therapeutics, Inc. (NASDAQ:CTMX), First Interstate BancSystem, Inc. (NASDAQ:FIBK), Global Net Lease, Inc. (NYSE:GNL), and Enable Midstream Partners, LP (NYSE:ENBL) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed December 18th, 2017. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

Intellia Therapeutics, Inc. (NTLA) REPORT OVERVIEW

Intellia Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Intellia Therapeutics reported revenue of $7.32MM vs $4.87MM (up 50.28%) and basic earnings per share -$0.44 vs -$0.22. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Intellia Therapeutics reported revenue of $16.48MM vs $6.04MM (up 172.65%) and basic earnings per share -$1.42 vs -$51.02. Intellia Therapeutics is expected to report earnings on March 13th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.31. The estimated EPS forecast for the next fiscal year is -$1.94 and is expected to report on March 13th, 2018.

To read the full Intellia Therapeutics, Inc. (NTLA) report, download it here: http://Fundamental-Markets.com/register/?so=NTLA

-----------------------------------------

United Community Banks, Inc. (UCBI) REPORT OVERVIEW

United Community Banks' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, United Community Banks reported interest income of $98.84MM vs $85.44MM (up 15.68%) and basic earnings per share $0.38 vs $0.36 (up 5.56%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, United Community Banks reported interest income of $335.02MM vs $278.53MM (up 20.28%) and basic earnings per share $1.40 vs $1.09 (up 28.44%). United Community Banks is expected to report earnings on January 24th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.40. The estimated EPS forecast for the next fiscal year is $1.79 and is expected to report on January 24th, 2018.

To read the full United Community Banks, Inc. (UCBI) report, download it here: http://Fundamental-Markets.com/register/?so=UCBI

-----------------------------------------

CytomX Therapeutics, Inc. (CTMX) REPORT OVERVIEW

CytomX Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, CytomX Therapeutics reported revenue of $24.14MM vs $3.45MM (up 599.02%) and basic earnings per share -$0.28 vs -$0.40. For the twelve months ended December 31st, 2016 vs December 31st, 2015, CytomX Therapeutics reported revenue of $15.04MM vs $7.71MM (up 95.06%) and basic earnings per share -$1.63 vs -$4.90. CytomX Therapeutics is expected to report earnings on March 1st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.39. The estimated EPS forecast for the next fiscal year is -$1.39 and is expected to report on March 1st, 2018.

To read the full CytomX Therapeutics, Inc. (CTMX) report, download it here: http://Fundamental-Markets.com/register/?so=CTMX

-----------------------------------------

First Interstate BancSystem, Inc. (FIBK) REPORT OVERVIEW

First Interstate BancSystem's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, First Interstate BancSystem reported interest income of $108.77MM vs $74.94MM (up 45.15%) and basic earnings per share $0.49 vs $0.57 (down 14.04%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, First Interstate BancSystem reported interest income of $297.43MM vs $282.42MM (up 5.31%) and basic earnings per share $2.15 vs $1.92 (up 11.98%). First Interstate BancSystem is expected to report earnings on January 25th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.57. The estimated EPS forecast for the next fiscal year is $2.63 and is expected to report on January 25th, 2018.

To read the full First Interstate BancSystem, Inc. (FIBK) report, download it here: http://Fundamental-Markets.com/register/?so=FIBK

-----------------------------------------

Global Net Lease, Inc. (GNL) REPORT OVERVIEW

Global Net Lease's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Global Net Lease reported revenue of $64.87MM vs $53.25MM (up 21.82%) and basic earnings per share $0.03 vs $0.16 (down 81.25%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Global Net Lease reported revenue of $214.17MM vs $205.33MM (up 4.31%) and basic earnings per share $0.81 vs -$0.03. Global Net Lease is expected to report earnings on February 26th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.63. The estimated EPS forecast for the next fiscal year is $2.12 and is expected to report on February 26th, 2018.

To read the full Global Net Lease, Inc. (GNL) report, download it here: http://Fundamental-Markets.com/register/?so=GNL

-----------------------------------------

Enable Midstream Partners, LP (ENBL) REPORT OVERVIEW

Enable Midstream Partners’ Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Enable Midstream Partners reported revenue of $705.00MM vs $620.00MM (up 13.71%) and basic earnings per share $0.24 vs $0.26 (down 7.69%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Enable Midstream Partners reported revenue of $2,272.00MM vs $2,418.00MM (down 6.04%) and basic earnings per share $0.68 vs -$1.78. Enable Midstream Partners is expected to report earnings on February 20th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.14. The estimated EPS forecast for the next fiscal year is $0.96 and is expected to report on February 20th, 2018.

To read the full Enable Midstream Partners, LP (ENBL) report, download it here: http://Fundamental-Markets.com/register/?so=ENBL

-----------------------------------------

ABOUT Fundamental Markets

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.